- the estimated total volume of treatment to be used;
- the trade name or generic name of the principle components or chemicals;
- the estimated amount of the principal components such as viscosifiers, acids, or gelling agents;
- the estimated weight or volume of inert substances such as proppants; and
- the maximum anticipated treating pressure or a written description of the well construction specifications which demonstrate that the well is appropriately constructed for the proposed fracture stimulation.
An owner, operator or service contractor need not disclose proprietary chemicals and trade secrets unless the information is needed to respond to (1) a spill or release or (2) a written request from a health professional who is treating a person who may have been exposed to the chemical concerned. The health professional must acknowledge verbally that he or she will maintain the confidentiality of the information and may be asked later to execute a nondisclosure agreement. In the case of a spill or release, upon request from the Montana Board of Oil and Gas, the trade secret information must be disclosed to Board members and staff or to a laboratory or other third-party, all of whom may be required to sign a nondisclosure agreement.
This post was written by Barclay Nicholson (barclay.nicholson@nortonrosefulbright.com or 713.651.3662) from Norton Rose Fulbright's Energy Practice Group.